TREVICTA susp inj 175 mg/0.875ml ser pré 0.875 ml

7680660540011 CH-66054 N05AX13 01.05.0.

Active substances:

TREVICTA susp inj 175 mg/0.875ml ser pré 0.875 ml
TREVICTA susp inj 175 mg/0.875ml ser pré 0.875 ml
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6605401
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
paliperidonum 175 mg ut paliperidoni palmitas 273 mg, polysorbatum 20, macrogolum 4000, acidum citricum monohydricum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 0.875 ml corresp. natrium 3.59 mg.

Articles (1)

Trevicta 175 mg/0.875 ml, Depot-Injektionssuspension in einer Fertigspritze
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
18/03/2025
Professional SmPC
Français
18/03/2025
Professional SmPC
Italien
18/03/2025

Detailed composition

Substance Quantity Type Category
paliperidonum
175.0 MG Substance Wirkstoff (Principe actif)
paliperidoni palmitas
273.0 MG Substance WIZUS
polysorbatum 20
- Substance HNIDK
macrogolum 4000
- Substance HNIDK
acidum citricum monohydricum
- Substance HNIDK
natrii dihydrogenophosphas monohydricus
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
3.59 MG Substance HBESI

Reimbursement information

Public price
CHF 740.95
Specialties list
Yes
Generic
No
SL addition date: 01/01/2017

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
66054
Drug name
Trevicta, Depot-Injektionssuspension in einer Fertigspritze
Galenic form
DEPISF
ATC Code
N05AX13
Authorization status
Z
Dispensation category
B
First authorization
16/11/2016
Authorization expiration date
31/12/9999
IT number
01.05.0.
Domain
Human medicine
Field of application
Neurolepticum

Packaging details

Description (FR)
TREVICTA susp inj 175 mg/0.875ml ser pré 0.875 ml
Description (DE)
TREVICTA Inj Susp 175 mg/0.875ml Fertspr 0.875 ml
Market launch
16/11/2016
Narcotic (BTM)
No

Available generics

Paliperidon-Mepha retard, Retardtabletten
CHF 120.25
View
Paliperidon-Mepha retard, Retardtabletten
CHF 120.25
View
Paliperidon-Mepha retard, Retardtabletten
CHF 159.50
View
Paliperidon Sandoz, Retardtabletten
CHF 120.25
View
Paliperidon Sandoz, Retardtabletten
CHF 120.25
View
Paliperidon Sandoz, Retardtabletten
CHF 159.50
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 91.10
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 138.90
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 186.40
View
Paliperidon Spirig HC retard, Depot-Injektionssuspension in einer Fertigspritze
CHF 224.60
View

Other packaging sizes

TREVICTA susp inj 263 mg/1.315ml ser pré 1.315 ml
1 FESP
View
TREVICTA susp inj 350 mg/1.75ml ser pré 1.75 ml
1 FESP
View
TREVICTA susp inj 525 mg/2.625ml ser pré 2.625 ml
1 FESP
View
Buy us a coffee Explore the data